Journal Menu
► ▼ Journal Menu-
- Medicina Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
12 June 2026
Medicina Webinar | Updates on Headaches: Challenges and Perspectives, 18 June 2026
A welcome message from the webinar Chair:
It is my great pleasure to welcome you to the webinar titled “Updates on Headaches: Challenges and Perspectives,” hosted by the journal Medicina (ISSN 1648-9144) on 18 June 2026. As headache disorders continue to evolve in clinical understanding and diagnostic challenges, our session aims to bring together experts to exchange insights on emerging concepts and future research directions. Our first speaker, Dr. Ayush Chandra, is an emerging neurology researcher from Nepal who will discuss his contributions to headache medicine and global health initiatives focused on migraine care. We will then hear from Dr. Alberto Ouro, who will present “Current and New Treatments for Headaches”, focusing on his research regarding bioactive lipids and sphingolipids as theragnostic tools in neurological diseases. Together, these presentations will explore the integration of biomarkers, precision neurology, and the diagnostic challenges we face in modern headache classification. I hope this webinar encourages meaningful scientific dialogue and inspires collaborative efforts to improve headache care and neurological research globally. We invite your participation during the Q&A session on critical themes, such as artificial intelligence and emerging treatments. Thank you for joining us for this productive and insightful session.
Date: 18 June 2026
Time: 9:00 a.m. EDT | 3:00 p.m. CEST
Webinar ID: 825 7708 9166
Webinar Secretariat: journal.webinar@mdpi.com
Register now for free!
Program:
| Speaker/Presentation | Time in EDT | Time in CEST |
| Dr. Anastasia Bougea Chair Introduction |
9:00–9:10 a.m. | 3:00–3:10 p.m. |
| Dr. Ayush Chandra Novel Headaches Classification: Challenges and Perspectives |
9:10–9:30 a.m. | 3:10–3:30 p.m. |
| Dr. Alberto Ouro Current and New Treatments for Headaches |
9:30–9:50 a.m. | 3:30–3:50 p.m. |
| Q&A Session | 9:50–10:05 a.m. | 3:50–4:05 p.m. |
| Closing Remarks Key Takeaways, Special Issue Submission, Acknowledgements |
10:05–10:15 a.m. | 4:05–4:15 p.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Dr. Anastasia Bougea, Department of Neurology, Medical School, National and Kapodistrian University of Athens, Greece & School of Electrical and Computer Engineering, National Technical University of Athens, Greece;
- Dr. Ayush Chandra, Multiple Sclerosis Society Nepal, Nepal & Department of Healthcare Management, Imperial Business College, Pokhara University, Nepal;
- Dr. Alberto Ouro, NeuroAging Laboratory Group (NEURAL), Spain, Clinical Neurosciences Research Laboratories (LINCs), Spain & Health Research Institute of Santiago de Compostela (IDIS), Spain.
11 June 2026
Medicina Receives an Increased CiteScore of 4.6
We are pleased to share that Medicina (ISSN: 1648-9144) has received an increased CiteScore of 4.6 in June 2026. The CiteScore ranks the journal 107 out of 669 titles (Q1) in the “General Medicine” category, an impressive achievement for a journal running in Volume 62.
You can find more statistics on our website.
The current CiteScores measure the average number of citations within a journal over a four-year window (2022–2025). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.
This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Medicina and its growing impact in the field of clinical and experimental investigations.
4 June 2026
Medicina Webinar | The Role of Multimodality Imaging in Heart Valve Disease: Focus on Aortic Stenosis and Mitral Regurgitation, 10 June 2026
This webinar aims to offer a comprehensive overview of the diagnosis and treatment of the most prevalent valvular heart diseases (aortic stenosis and mitral regurgitation).
Since these patients require a multimodality imaging approach to diagnose the severity of valvular disease and to plan the best treatment, experienced imaging cardiologists will join this meeting to discuss updates on valvular disease, following the publication of the latest ESC guidelines. Beyond current therapeutic standards, the speakers will present updated evidence regarding new treatments and recommendations, their specific indications, and ideal treatment timings.
This webinar is aimed not only at imaging cardiologists but also clinical cardiologists, cardiac surgeons, anesthesiologists, and general practitioners, as recent advances in this field have dramatically improved the survival and quality of life of affected individuals.
Date: 10 of June 2026 at 3:00 p.m. CEST | 9:00 a.m. EDT
Webinar ID: 881 7234 4989
Register now for free!
Program:
|
Speaker/Presentation |
Time in CEST |
|
Maria Lo Monaco |
3:00–3:10 p.m. |
|
Federico Marchini |
3:10–3:30 p.m. |
|
Kamil Stankowski |
3:30–3:50 p.m. |
|
Q&A Session |
3:50–4:10 p.m. |
|
Maria Lo Monaco |
4:10–4:15 p.m. |
After registering, you will receive a confirmation email containing instructions for how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we’ll let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Dr. Maria Lo Monaco, Department of Cardio-Imaging, Humanitas Gavazzeni Hospital, Bergamo, Italy;
- Dr. Federico Marchini, Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Ferrara, Italy;
- Dr. Kamil Stankowski, Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milano, Italy.
“The Role of Multimodality Imaging in Valve Diseases”
Guest Editor: Dr. Maria Lo Monaco
Submission deadline: 25 July 2026
4 June 2026
Open Access, Broadly Recognized: 363 MDPI Journals Receive CiteScores for 2025
The 2025 CiteScore metrics have been officially released by Scopus, and the results confirm what has become a consistent pattern for MDPI's journal portfolio: broad recognition across disciplines, steady improvement across the majority of ranked titles, and a growing presence at the top of subject category rankings.
CiteScore, published annually by Elsevier's Scopus database, measures the average citations received by articles published in a journal over a four-year window. As a complement to the Journal Impact Factor, which uses a two-year window based on the Web of Science database, CiteScore provides an alternative, long-term perspective on citation performance.
The 365 MDPI journals in Scopus (as of May 2026) are indexed across a wide range of subject categories, ensuring that open access research remains highly discoverable to a global readership through one of the most widely used platforms in academic publishing.
Data Summary (2025 CiteScores)
- New Additions: 41 MDPI journals received a CiteScore for the first time.
- Trending Upward: 234 of 322 previously ranked journals (73%) saw an increase in their CiteScore compared to last year.
- High Visibility: 314 journals (86%) rank in Q1 or Q2 in at least one subject category.
- Elite Performance: 42 journals rank in the top 10% of their subject categories.
Portfolio Performance
Among the 322 journals that held a CiteScore in 2024, 234 saw an increase this year. Quartile improvements outnumbered declines across the portfolio, with 52 journals moving to a higher quartile and only 20 seeing a decline. Furthermore, no previously ranked journals were removed. The 42 journals now ranked in the top 10% of their subject categories are drawn from a strong foundation of 178 journals holding a Q1 position.
With the large majority of our indexed portfolio ranked in the top half of research fields, researchers can confidently choose MDPI to meet funder mandates for high-quality, fully compliant Open Access publishing.
Exceptional Achievements for Foods and Life
Notably, both Foods and Life achieved a 99th percentile ranking in their respective subject categories for the 2025 CiteScores. This outstanding placement positions them as leading journals in their fields and highlights the high visibility and global impact of the open access research they publish.
Journal Metrics and Beyond
Journal-level metrics describe outlets, not individual articles. An increasing number of funders and institutions—including signatories of DORA and the Coalition for Advancing Research Assessment—now explicitly encourage evaluation at the article level rather than by the journal in which research appears. MDPI supports this direction: we report CiteScore alongside the Journal Impact Factor, Journal Citation Indicator, and article-level usage data because no single number captures the full reach and contribution of published research.
Thank You
These results reflect the sustained effort of thousands of editors-in-chief, editorial board members, reviewers, and authors across every field MDPI serves. The metrics are the outcome; the work is yours.
3 June 2026
Empowering Academic Growth with MDPI Academic Publishing Workshop at Chulabhorn International College of Medicine, Thammasat University, 24 June 2026
We are delighted to announce the MDPI Academic Publishing Workshop, organized in partnership with Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, in collaboration with the MAS Neuroscience Center, School of Anti-Aging and Regenerative Medicine, Mae Fah Luang University, Bangkok. This joint effort reflects a shared commitment to advancing interdisciplinary research that tackles global challenges through innovative methodologies, cross-sector cooperation, and transformative approaches.
As part of our ongoing dedication to researcher development, the workshop seeks to strengthen the research capacity of the academic community across both institutions. Participants will have the opportunity to explore emerging trends, gain insights into open access publishing practices, and engage directly with journal editors and publishing professionals. Designed especially for early-career researchers and innovators, the workshop will provide practical skills to help attendees enhance the visibility and impact of their work while fostering meaningful international collaborations.
Date: 24 June 2026
Time: 12:00 p.m.–4:00 p.m.
Location: Classroom AB-80, 5th Floor, Integrated Academic and Laboratory Building, Chulabhorn International College of Medicine, Rangsit Center, Thammasat University, Thailand
Language: Thai
Registration: https://www.surveymonkey.com/r/6R2WDF5
|
Speaker |
Program |
Time |
|
|
Registation |
12:00–1:00 p.m. |
|
Asst. Prof. Dr. Peerapong Kitupawong, Dean of Chulabhorn International College of Medicine, Thammasat University |
Opening Speech |
1:00–1:10 p.m. |
|
Dr. Siriporn Tantiwatcharothai |
MDPI and Journal Introduction |
1:10–1:30 p.m. |
|
Assoc. Prof. Sattrachai Prasopdee |
Behind the Submission: Real Experiences in Journal Selection |
1:30–1:45 p.m. |
|
Asst. Prof. Chuntida Kamalashiran |
Publishing Integrative Medicine Research |
1:45–2:00 p.m. |
|
Dr. Juthathip Poofery |
How to Write Scientific Papers |
2:00–2:30 p.m. |
|
|
Q&A Session and Coffee Break |
2:30–2:40 p.m. |
|
Dr. Krit Inthajak |
MDPI Editorial Process and Peer Review Process |
2:40–3:00 p.m. |
|
|
Q&A Session |
3:00–3:10 p.m. |
|
Ms. Hathaipat Kittirojana |
How to Respond to Peer Reviewers |
3:10–3:40 p.m. |
|
|
Q&A Session |
3:40–3:50 p.m. |
|
|
Closing & Certificate Awarding Ceremony |
3:50–4:00 p.m. |
| Chair: |
|
|
|
Asst. Prof. Dr. Peerapong Kitupawong, MD, is the Dean of Chulabhorn International College of Medicine, Thammasat University, Thailand. |
|
Guest Speakers: |
|
|
|
Assoc. Prof. Sattrachai Prasopdee is an Associate Professor of parasitology. He earned his bachelor’s degree in veterinary medicine from the Faculty of Veterinary Medicine, Khon Kaen University, and his doctoral degree from the Faculty of Medicine, Khon Kaen University. His research focuses on Opisthorchis viverrini infection and the control and diagnosis of cholangiocarcinoma. His current work emphasizes One Health research aimed at preventing and controlling parasitic diseases across human, animal, and environmental domains. |
|
|
Asst. Prof. Chuntida Kamalashiran is an Assistant Professor of integrtive of medicine. She graduated with her bachelor’s degree in Applied Thai Traditional Medicine from the Faculty of Pharmacy Medicine, Mahasarakham University, and with her doctoral degree in Integrative Medicine from Chulabhorn International College of Medicine, Thammasat University. The research focuses on clinical trial in Alternative, Thai Traditional and Integraive Medicine. Her current work focuses on eldery diseases, neuroscicene and integrative medicine. |
|
MDPI Speakers: |
|
|
|
Dr. Siriporn Tantiwatcharothai obtained her PhD in applied chemistry from the Faculty of Science, King Mongkut's Institute of Technology Ladkrabang. She joined MDPI in December 2022 as an Assistant Editor for Catalysts. In 2024, she was promoted to Section Managing Editor and served as a Chief Section Managing Editor in April 2025. Currently, she is one of MDPI's Regional Engagement Editors for the Asia–Pacific region. |
|
|
Dr. Juthathip Poofery holds a PhD in biochemistry from the Faculty of Medicine, Chiang Mai University, Thailand. She began working at MDPI in 2021 as an Assistant Editor for Medicina and advanced to the position of Section Managing Editor in 2022. Since 2023, Dr. Poofery has been serving as the Group Leader of the Medical Science Section, where she oversees editorial operations and contributes to the advancement of research in the field. She currently works as a Regional Engagement Editor for the Asia–Pacific region.
|
|
|
Dr. Krit Inthajak obtained his PhD in engineering and technology from Sirindhorn International Institute of Technology, Thammasat University. He joined MDPI in March 2020 as an Assistant Editor for Molecules. He was appointed as a Section Managing Editor in 2021 and worked as a Group Leader from 2021 to 2024. He is now one of MDPI's Regional Engagement Editors for the Asia–Pacific region. |
|
|
Ms. Hathaipat Kittirojana obtained her master’s degree in food science and biotechnology from Teesside University. She joined MDPI in December 2020 as an Assistant Editor for the Journal of Imaging. She was appointed as a Section Managing Editor in March 2023 and a Regional Engagement Editor for the Asia–Pacific region in July 2024. |
1 June 2026
MDPI INSIGHTS: The CEO’s Letter #35 – 30 Years of Open Science, Open Access Policies, Spain Summit, MMCS 2026 & Antibiotics 2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

30 Years of Open Science, Built Together
This month, we officially launched MDPI’s 30th Anniversary campaign and dedicated anniversary website, marking an important milestone in our journey as an open access publisher. What began in 1996 with a single journal and the simple belief that scientific knowledge should be shared openly and freely has grown into a global publishing organization supporting more than 500 journals, 68,000 Editorial Board Members, and millions of researchers worldwide.
The anniversary page, entitled 30 Years of Open Science, Built Together, reflects on the people, milestones, and partnerships that have shaped MDPI over the past three decades. It includes a retrospective of our development, key moments in the evolution of open access, landmark research articles, journal anniversaries, an interview with the CEO, and perspectives from colleagues and partners who have contributed to our success.

Looking back, one of the most striking aspects of our journey is not simply our growth, but the broader transformation of scholarly publishing itself.
Open access has moved from a niche concept to a widely adopted publishing model, helping make research more accessible, discoverable, and impactful for researchers, institutions, policymakers, and society.
MDPI has been part of this transition and continues to invest in the people, technology, partnerships, and research integrity infrastructure needed to support high-quality open science at scale.
While anniversaries naturally encourage reflection, they are also an opportunity to look ahead. The challenges facing scholarly publishing today, including research integrity, artificial intelligence, accessibility, and global participation in science, will require continued collaboration across the research ecosystem. As we celebrate 30 years of publishing, our focus remains on supporting researchers, strengthening trust in open science, and helping shape the future of scholarly communication together.
I encourage you to visit the anniversary page, explore the milestones, and take a moment to reflect on the role each of us has played in contributing to MDPI’s story.
Thank you for being part of this journey.
Impactful Research

Highlights from MMCS 2026 in Beijing (14-17 May)
From 14–17 May, MDPI hosted The 5th Molecules Medicinal Chemistry Symposium (MMCS 2026) in Beijing, China, bringing together academia and industry to explore advances in chemical biology, medicinal chemistry, and drug discovery.
The conference hosted more than 230 attendees from 37 countries and regions, alongside 257 submissions and 145 accepted abstracts. With a significant increase in attendance – up by 100 participants compared with the previous edition – the popularity of MMCS continues to grow in terms of its international profile and scientific relevance within this rapidly evolving field.

The scientific program covered seven themes:
- Chemical Biology for Drug Discovery
- Medicinal Chemistry Research Progress
- Natural Products in Drug Discovery
- AI-enabled Drug Discovery
- GPCR & Ion Channel Targeted Drug Development
- Innovative Proximity-Based Drug Modalities
- Biocatalysis for Natural Product & Drug Synthesis
The event featured three plenary speakers, 14 keynote speakers, 35 selected oral presentations, and 98 poster presentations, creating opportunities for open scientific exchange and collaboration. Conference Chair Prof. Dr. Diego Muñoz-Torrero described this edition as one of the most successful MMCS events to date.
|
|
|
Thanks to our Sponsors
MMCS 2026 secured sponsorship support from 12 industrial partners, 11 of which set up on-site exhibition booths. Covering biopharmaceutical R&D, life science supplies, pharmaceutical experimental instruments, and industrial service sectors, exhibitors were able to connect their businesses directly with attendees and make connections at the conference.

30th Anniversary Celebration of Molecules
During the conference, we also celebrated the 30th anniversary of Molecules, one of MDPI’s flagship journals. The celebration brought together Section Editors-in-Chief, Editorial Board Members, MDPI leadership, and editorial colleagues to reflect on the journal’s development, achievements, and continued future growth.

Events such as MMCS 2026 highlight the important role conferences play in creating scientific exchange and collaboration, and in connecting our research communities in person.
They also reflect the continued development of MDPI’s conference portfolio and our commitment to supporting academic engagement beyond publishing alone. Thanks to everyone involved in organizing and contributing to the success of this event.
Inside MDPI

Open Access Policies Continue to Accelerate Globally
One of the clearest indicators of the continued momentum behind open access is the growing number of national and institutional policies supporting, and increasingly requiring, open dissemination of research.
Around the world, governments, funding agencies, and universities are building their open access mandates, with increasing focus on transparency, rights retention, and public accessibility of publicly funded research. While these policies vary across regions, the broader direction is clear: expectations around openness and compliance continue to accelerate.
For researchers, navigating these evolving requirements can be complex and time-consuming. Supporting the research community therefore means not only publishing high-quality open access content but also helping stakeholders better understand changing requirements and emerging opportunities. At MDPI, we see this as an important part of our role within scholarly communication.
“Expectations around openness and compliance continue to accelerate”
Through the MDPI Blog, our Content team continues to publish monthly articles overviewing different countries’ relationships with open access, exploring their histories, policies, opportunities, and statistics. All this information is centralized into an article which contains brief summaries of each country, with links to all the full articles, and is updated monthly.
Recent Policy Developments
South Africa
In 2026, South Africa’s Department of Science and Innovation introduced the South African Open Science Policy. The policy states that: “Open access shall be required for publications arising from publicly funded research, and desirable for research from all sources of funding.”
The policy envisions a coordinated and broad approach to open science that will sustainably and ethically drive socio-economic development by increasing the practice of open science through policy, training, incentivization, and infrastructure.
Canada
In Canada, the Tri-Agency OA Policy on Publications was revised, removing the 12-month embargo for research that must be deposited in a repository with an open license and with author rights retained.
The Agencies argue that “societal advancement is made possible through widespread and barrier-free access to cutting-edge research and knowledge.”
Chile
Chile is a collaborative and engaged member of the global open access movement.
The National Research and Development Agency (Agencia Nacional de Investigación y Desarrollo, or ANID) is Chile’s main funding agency for R&D. It mandates that all beneficiaries must deposit the final version of their published scientific output, with an embargo period of up to 12 months, into a repository.
ANID also supports the InES Open Science funding program, which allows universities to request funding for capacity and infrastructure building. Further, Chile is an active participant in various international initiatives, such as Redalyc, SciELO, and Red de Repositorios Latinoamericanos.
Openness Beyond Research
At MDPI, openness remains one of our core values, ensuring that research outputs are freely accessible to anyone. This commitment also extends to sharing knowledge about the scholarly publishing landscape itself, which we practice on the MDPI Blog through various topics, including open access, recent advances in science, and opportunities for researchers.
As the open access landscape continues to evolve, helping researchers, institutions, editors, and partners navigate these changes will remain an important priority for us.

Thank You
I would like to thank Jack McKenna (Senior Content Specialist, MDPI) from our Content team for his ongoing work on the MDPI Blog series covering global open access policy developments. Initiatives such as this help make complex policy discussions more accessible and useful to the wider research community.
Coming Together for Science

Reflections from the MDPI Spain Summit 2026 in Valencia (21 May)

On 21 May, we hosted the MDPI Spain Summit 2026 in Valencia.
The Summit brought together 30 Editorial Board Members and MDPI colleagues for a discussions on the future of publishing, research integrity, peer review, artificial intelligence, and the evolving research landscape in Spain.
We hosted participants from leading Spanish institutions and spoke on the importance of Spain as a major contributor to global open access (OA) research. In 2025 alone, Spain ranked among the leading countries worldwide for OA publishing, with more than 85% of publications made openly accessible. MDPI also continues to play a significant role within the Spanish research ecosystem.
MDPI in Spain
Spain remains one of MDPI's most important academic markets and a leading contributor to OA research globally. Ever since our Barcelona office opened in 2016 (Happy 10th Anniversary!), MDPI Spain has been actively supporting researchers, institutions, societies, and academic partners across the country. Today, the office plays an important role in creating engagement with the Spanish scholarly community through editorial support, partnerships, conferences, training initiatives, and outreach activities.
A cluster of high-level indicators highlight both the strength of the local research ecosystem and MDPI’s role within it:
- 43,218 total publications in Spain in 2025, of which 35,728 (83%) were open access (49% Gold OA).
- 211,200+ total publications (2021–2025), with 84% published open access.
- 13,444 MDPI publications from Spanish institutions in 2025, representing 14% of all open access publications in Spain.
- More than115,100 MDPI publications from Spanish institutions since 1996.
- More than 4,500 Editorial Board Members from Spain, including more than 150 Chief Editors and 57 Associate Editors.
- 42 institutional partners participating in MDPI’s Institutional Open Access Program (IOAP).
- Spain ranks second globally for MDPI society affiliations, with 26 affiliated society agreements currently in place.
Program Overview
What made this summit special was the openness of the discussions around the research landscape in Spain and the role MDPI plays within the market. General topics of the presentations included:
- MDPI Introduction – Stefan Tochev (CEO).
- Engagement with the Academic Community – Dr. Marta Colomer (External Affairs Lead).
- Latest Developments in the Editorial Process – Dr. Jordi Martinez (Deputy Managing Editor).
- Research integrity and Publication Ethics – Slavomir Nikodijevic (Research Integrity Specialist).
- A 360 View of Academic Publishing – Prof. Dr. Luis Angel Ruiz Fernandez (EBM of Remote Sensing).
|
|
|
|
|
|
|
|
Panel Discussion
We also hosted a panel discussion moderated by Marta, entitled “The Future of Academic Publishing” with Prof. Luis Ruiz, Prof. Marta Feliz (EBM of the journal Catalysts), Dr. Enric Sayas (Product Owner, AI & Technology Innovation), and myself. The discussion looked at the evolving role of editors, the future of peer review, and the growing importance of maintaining trust, ethics, and research integrity in an era increasingly influenced by artificial intelligence.
|
|
|
|
Themes from the Summit
Several themes emerged throughout the discussions, reflecting broader conversations taking place across publishing:
- The academic community values efficient publishing workflows, but expectations around scientific quality and editorial rigor continue to rise.
- Reviewer fatigue and long-term sustainability of peer review remain major challenges across the industry.
- AI is rapidly changing scholarly communication and requires transparent and responsible governance.
- Reputation and trust continue to depend on long-term engagement, transparency, and quality-focused decision-making.
“Maintaining an open dialogue with researchers, editors, reviewers, and institutions remains a priority for MDPI”
It was constructive to see the willingness of participants to engage directly and candidly with us. These conversations provide insights that help inform how we continue to develop our editorial processes, engagement activities, and support for the research community. While certain discussions included concerns, there was also recognition that open dialogue between publishers and the research community is essential if we want to improve scholarly communication together.
|
|
|
|
Events such as this are increasingly important for MDPI. They allow us to present our perspective, to listen to the experiences, expectations, and concerns of editors, reviewers, and researchers, and to address these accordingly.
Thank You
Thank you to our Barcelona Office and all colleagues involved in organizing the summit, as well as all participants for contributing to these thoughtful and constructive discussions.
|
|
|
|
|
|
|
|
As publishing continues to evolve, maintaining an open dialogue with researchers, editors, reviewers, and institutions remains an important priority for MDPI. Events such as the Spain Summit play an important role in helping us to build relationships, foster trust, and better understand the needs of our community.
Closing Thoughts

Highlights from Antibiotics 2026 in Barcelona (11–14 May)
This week, MDPI hosted the Antibiotics 2026 — Advances in Antimicrobial Action and Resistance conference in Barcelona, bringing together academics and industry experts to discuss one of the most important scientific and public health challenges of our time: antimicrobial resistance.
The conference welcomed 145 attendees from 42 different countries and territories, alongside 265 submissions and 127 accepted abstracts, showing the international reach of the event and the strong scientific interest in this rapidly evolving field.

Scientific Exchange on a Global Challenge
Antimicrobial resistance continues to be a global concern, creating collaboration across disciplines, institutions, and regions. The conference program focused on a range of topics including:
- Antimicrobial resistance mechanisms
- One Health approaches to antimicrobial stewardship
- Discovery of novel antimicrobial agents
- Innovation in clinical strategies and treatment approaches
- Ethnopharmacology and emerging therapies
Through keynote plenaries, invited lectures, oral presentations, and poster sessions, the conference created a platform for dialogue and scientific exchange.
|
|
|
International Participation and Collaboration
One of the highlights of the event was the diversity of participation across both geography and expertise. Researchers and speakers from Europe, North America, Asia, Africa, Australia, and Latin America took part in discussions throughout the conference, highlighting the global nature of both the challenge and the scientific response.
The scientific program included:
- 2 keynote speakers
- 10 invited speakers
- 36 selected talks
- 78 posters
The conference brought together perspectives from academia, healthcare, and industry, helping facilitate interdisciplinary collaboration around future approaches to antimicrobial research and resistance management.
|
|
|
|
The Role of Conferences in Scholarly Communication
Conferences are an important platform for collaboration, scientific exchange, and community-building. Events such as Antibiotics 2026 show the value of bringing researchers together in person to discuss emerging challenges, share new findings, and strengthen international networks across disciplines and regions.

Thank You
I would like to thank the conference chairs, speakers, participants, sponsors, and the entire MDPI conference team for their work in making this event a success. The engagement and positive feedback from attendees highlight the importance of our events in addressing some of the most pressing scientific challenges facing society today.

Chief Executive Officer
MDPI AG
27 May 2026
Medicina | Highly Cited Papers Published in 2024–2025 and Hot Topic Special Issues in the “Intensive Care/ Anesthesiology” Section
We would like to share some highly cited papers from the “Intensive Care/ Anesthesiology” Section of Medicina (ISSN: 1648-9144) published in 2024–2025, which you are welcome to read. You can also find the journal’s latest publications via the following link: https://www.mdpi.com/search?journal=medicina§ion=1109.
Additionally, some Special Issues in the “Intensive Care/ Anesthesiology” Section are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:
1. “Sepsis-Associated Acute Kidney Injury: Where Are We Now?”
by Dimitris Kounatidis, Natalia G. Vallianou, Sotiria Psallida, Fotis Panagopoulos, Evangelia Margellou, Dimitrios Tsilingiris, Irene Karampela, Theodora Stratigou and Maria Dalamaga
Medicina 2024, 60(3), 434; https://doi.org/10.3390/medicina60030434
Available online: https://www.mdpi.com/1648-9144/60/3/434
2. “Interleukin-6 and Leukocyte Cell Population Data in Newly Diagnosed Sepsis—A Prospective Study”
by Sara Šundalić, Iva Košuta, Ivana Baršić Lapić, Ivana Rako, Dunja Rogić, Radovan Radonić and Ana Vujaklija Brajković
Medicina 2025, 61(3), 468; https://doi.org/10.3390/medicina61030468
Available online: https://www.mdpi.com/1648-9144/61/3/468
3. “Assessment of Preoperative Anxiety and Influencing Factors in Patients Undergoing Elective Surgery: An Observational Cross-Sectional Study”
by Juseok Oh, Wonjin Lee, Seunghee Ki, Jaewoo Suh, Seokwoo Hwang and Jeonghan Lee
Medicina 2024, 60(3), 403; https://doi.org/10.3390/medicina60030403
Available online: https://www.mdpi.com/1648-9144/60/3/403
4. “Comparison of the Safety and Efficacy of Remimazolam and Propofol for Sedation in Adults Undergoing Colonoscopy: A Meta-Analysis of Randomized Controlled Trials”
by Bon-Wook Koo, Hyo-Seok Na, Sang-Hi Park, Seunguk Bang and Hyun-Jung Shin
Medicina 2025, 61(4), 646; https://doi.org/10.3390/medicina61040646
Available online: https://www.mdpi.com/1648-9144/61/4/646
5. “A Contemporary Review of Blood Transfusion in Critically Ill Patients”
by Sumeet K. Yadav, Guleid Hussein, Bolun Liu, Nikhil Vojjala, Mohamed Warsame, Mohamad El Labban, Ibtisam Rauf, Mohamed Hassan, Tashfia Zareen, Syed Muhammad Usama et al.
Medicina 2024, 60(8), 1247; https://doi.org/10.3390/medicina60081247
Available online: https://www.mdpi.com/1648-9144/60/8/1247
6. “Remifentanil Patient-Controlled Analgesia for Labor Analgesia at Different Cervical Dilations: A Single Center Retrospective Analysis of 1045 Cases”
by Tatjana Stopar Pintaric, Lara Vehar, Alex T. Sia, Tomislav Mirkovic and Miha Lucovnik
Medicina 2025, 61(4), 675; https://doi.org/10.3390/medicina61040675
Available online: https://www.mdpi.com/1648-9144/61/4/675
7. “Latest Advances in Regional Anaesthesia”
by Frances Fallon, Aneurin Moorthy, Conor Skerritt, Gillian G. Crowe and Donal J. Buggy
Medicina 2024, 60(5), 735; https://doi.org/10.3390/medicina60050735
Available online: https://www.mdpi.com/1648-9144/60/5/735
8. “Rebound Pain After Regional Anaesthesia”
by Frances Fallon, Mohd Shazrul Ramly and Aneurin Moorthy
Medicina 2025, 61(5), 790; https://doi.org/10.3390/medicina61050790
Available online: https://www.mdpi.com/1648-9144/61/5/790
9. “Effect of Remimazolam- versus Propofol-Based Total Intravenous General Anesthesia on Intraoperative Hemodynamic Stability for Major Spine Surgery in the Prone Position: A Randomized Controlled Trial”
by Ha-Jung Kim, Ji-Young Kim, Hyeok-Seong Park, Hyungtae Kim, Young-Jin Ro and Won Uk Koh
Medicina 2024, 60(3), 432; https://doi.org/10.3390/medicina60030432
Available online: https://www.mdpi.com/1648-9144/60/3/432
10. “Sepsis Burden in a Major Romanian Emergency Center—An 18-Year Retrospective Analysis of Mortality and Risk Factors”
by Florentina Mușat, Dan Nicolae Păduraru, Alexandra Bolocan, Cosmin-Alexandru Palcău,
Andrei-Alexandru Bunea, Daniel Ion and Octavian Andronic
Medicina 2025, 61(5), 864; https://doi.org/10.3390/medicina61050864
Available online: https://www.mdpi.com/1648-9144/61/5/864
Special Issues:
“Multidisciplinary Approaches and Recent Advances in Anesthesiology and Critical Care”
Guest Editors: Dr. Silvius Ioan Negoiţǎ, Dr. Dan E. Corneci and Dr. Emanuel Moisa
Submission deadline: 30 September 2026
“Precision and Regenerative Interventional Pain Medicine: Imaging-Guided, Neuromodulatory and Minimally Invasive Advances”
Guest Editors: Dr. Giuliano Lo Bianco, Dr. Alaa Abd-Elsayed and Dr. Leonardo Kapural
Submission deadline: 1 October 2026
“Global Perspectives on Sepsis: Epidemiology, Awareness and Treatment Strategies”
Guest Editor: Dr. Alice Dragoescu
Submission deadline: 15 October 2026
“Novel Therapeutic Strategies in Extracorporeal Life Support for Critical Care”
Guest Editor: Dr. Stavros Dimopoulos
Submission deadline: 31 October 2026
Subscribe to Medicina at https://www.mdpi.com/journal/medicina#journal-alerts.
21 May 2026
Empowering Academic Growth with MDPI Academic Publishing Workshop at Chiang Mai University, 5 June 2026
We are excited to announce the MDPI Academic Publishing Workshop, which will be hosted in partnership with Chiang Mai University. This collaboration reflects a mutual commitment to advancing interdisciplinary research that responds to global sustainability challenges through innovative approaches, cross-sector collaboration, and transformative solutions.
Designed with early-career researchers and innovators in mind, the workshop will provide practical skills to assist participants in increasing the impact of their scholarly work and building meaningful international connections.
Date: 5 June 2026
Time: 9:30 a.m.–3:00 p.m.
Location: Lecture Room 0410, 4th Floor, The Multidisciplinary Building, Faculty of Medicine, Chiang Mai University
Language: Thai
Registration: https://www.surveymonkey.com/r/6R2WDF5
|
Speaker |
Program |
Time |
|
Assoc. Prof. Dr. Apichat Tantraworasin, Head of the Clinical Epidemiology and Clinical Statistics Center and Associate Dean for Postgraduate Affairs at the Faculty of Medicine, Chiang Mai University |
Opening Speech |
9:30–9:40 a.m. |
|
Mr. Pongsakorn Vithayanon |
MDPI and Journal Introduction |
9:40–10:00 a.m. |
|
Dr. Juthathip Poofery |
How to Write Scientific Papers in English |
10:00–10:40 a.m. |
|
|
Q&A Session |
10:40–10:50 a.m. |
|
Ms. Hathaipat Kittirojana |
How to Respond to Peer Reviewers |
10:50–11:20 a.m. |
|
|
Q&A Session |
11:20–11:30 a.m. |
|
Ms. Ploy Assavajamroon |
Artificial Intelligence in Scientific Publishing |
11:30–11:50 a.m. |
|
|
Q&A Session |
11:50 a.m.–12:00 p.m. |
|
|
Lunch Break |
12:00–1:00 p.m. |
|
Dr. Siriporn Tantiwatcharothai |
Publication Ethics for Authors |
1:00–1:30 p.m. |
|
|
Q&A Session |
1:30–1:40 p.m. |
|
Ms. Pratthana Kruekantha |
How to Make Good Figures for Scientific Papers |
1:40–2:10 p.m. |
|
|
Q&A Session |
2:10–2:20 p.m. |
|
Ms. Pratthana Kruekantha |
How to Design Tables in Scientific Papers |
2:20–2:50 p.m. |
|
|
Q&A Session |
2:50–3:00 p.m.
|
|
Chair |
|
|
|
Assoc. Prof. Dr. Apichat Tantraworasin is an Associate Professor of surgery, currently serving as Head of the Clinical Epidemiology and Clinical Statistics Center and Associate Dean for Postgraduate Affairs at the Faculty of Medicine, Chiang Mai University. |
|
MDPI Speakers: |
|
|
|
Mr. Pongsakorn Vithayanon obtained his master’s degree in food biotechnology from The Faculty of Biotechnology, Assumption University. He joined MDPI in February 2023 as an Assistant Editor for International Journal of Molecular Sciences (IJMS). He was appointed as a Section Managing Editor in 2024 and worked as a Group Leader from 2024 to present. He is now one of MDPI’s Deputy Managing Editor for the Editorial Office of IJMS. |
|
|
Dr. Juthathip Poofery holds a Ph.D. in biochemistry from the Faculty of Medicine, Chiang Mai University, Thailand. She began working at MDPI in 2021 as an Assistant Editor for Medicina and advanced to the position of Section Managing Editor in 2022. Since 2023, Dr. Poofery has been serving as the Group Leader of the Medical Science Section, where she oversees editorial operations and contributes to the advancement of research in the field. She currently works as a Regional Engagement Editor for the Asia–Pacific region. |
|
|
Ms. Hathaipat Kittirojana obtained her master’s degree in food science and biotechnology from Teesside University. She joined MDPI in December 2020 as an Assistant Editor for the Journal of Imaging. She was appointed as a Section Managing Editor in March 2023 and a Regional Engagement Editor for the Asia–Pacific region in July 2024. |
|
|
Ms. Ploy Assavajamroon obtained her master’s degree in chemistry from Thammasat University, Thailand, in 2020 and joined MDPI as an Assistant Editor for the journal Crystals in the same year. She became a Section Managing Editor in 2021 and a Group Leader in 2022. She is currently one of MDPI’s Regional Engagement Editors for the Asia–Pacific region. |
|
|
Dr. Siriporn Tantiwatcharothai obtained her Ph.D. in Applied Chemistry from the Faculty of Science, King Mongkut's Institute of Technology Ladkrabang. She joined MDPI in December 2022 as an Assistant Editor for Catalysts. In 2024, she was promoted to Section Managing Editor, and served as a Chief Section Managing Editor in April 2025. Currently, she is one of MDPI's Regional Engagement Editors for the Asia–Pacific region. |
|
|
Ms. Pratthana Kruekantha is a chemistry graduate from Chiang Mai University and has been with MDPI since June 2022. Now a Proofreading Editor, she has built a solid production foundation across roles including Final Checker, Cross Checker, and LaTeX Editor. A certified Layout and Conversion Tutor, she also served as a Training Assistant for one year, actively supporting the Production Department’s learning and development initiatives. |
19 May 2026
Interview with Dr. Anastasia Bougea—Winner of the Medicina Editor of Distinction Award
1. Could you briefly introduce your academic background and current research focus?
I am a neurologist and clinical researcher holding an MD, MSc, and PhD, with extensive postdoctoral training. My primary clinical and scientific focus centers on neurodegenerative disorders, specifically Parkinson’s disease, Alzheimer’s disease, and atypical Parkinsonian syndromes. I am currently investigating the use of fluid biomarkers, such as alpha-synuclein and tau proteins, to improve early diagnostic accuracy and track disease progression. Additionally, I am deeply engaged in the intersection of artificial intelligence and clinical medicine; I am currently pursuing a master’s candidate degree in “Translational Engineering in Health and Medicine” at the National Technical University of Athens, Greece. This allows me to explore how machine learning algorithms and digital biomarkers can be leveraged to standardize and enhance clinical workflows.
2. How was your experience being an editor for Medicina? What motivated you to participate actively in the editorial process, and what do you find most rewarding about it?
Serving as an Editor for the “Neurology” Section and leading Special Issues on topics like biomarkers and non-motor disorders has been a highly fulfilling journey. My motivation stems from a deep commitment to advancing the field; the peer-review process is the absolute bedrock of scientific integrity. As a peer reviewer educator for the Movement Disorder Society, the most rewarding aspect of this role is working collaboratively with authors and reviewers to refine manuscripts. Helping to ensure that rigorous, high-impact research reaches the medical community—and ultimately translates into better patient care—is incredibly gratifying.
3. As a journal Editorial Board Member, what do you believe is the most critical step in maintaining the journal’s academic standards? Is it the evaluation of innovation during the precheck stage, the precise selection of reviewers, or the final decision of controversial manuscripts?
While the precheck stage and the final editorial decisions are undeniably important, the precise selection of expert reviewers is the most critical step. Reviewers are the gatekeepers of scientific validity. Identifying peers with the exact methodological and clinical expertise required for a specific paper ensures a fair, rigorous, and constructive evaluation. It is this robust foundation of peer review that empowers the editorial board to make sound, evidence-based final decisions, especially when navigating controversial or highly novel manuscripts.
4. How do you see the role of editors evolving with the advancements in artificial intelligence and automated tools in research publishing?
Artificial intelligence and automated tools are rapidly transforming research publishing, much like they are reshaping clinical diagnostics. I see AI serving as a powerful complementary tool for editors—assisting with plagiarism detection, formatting checks, and even suggesting appropriate reviewers by mapping complex academic networks. However, the core editorial responsibilities—evaluating true clinical innovation, navigating ethical nuances, and exercising complex scientific judgment—cannot be automated. Editors will evolve into curators who leverage AI for efficiency while providing the indispensable human oversight required to maintain the soul and standard of scientific inquiry.
5. Do you have any advice for early career researchers in terms of research or publishing?
Embrace interdisciplinary collaboration and maintain unwavering methodological rigor. The most significant breakthroughs often happen at the intersection of different fields, such as merging clinical neurology with computational engineering. Rejections and extensive revisions are an inevitable part of publishing, so it is vital to cultivate resilience and view the peer-review process as a constructive mechanism to elevate your work. Finally, actively seek out mentorship, continuously educate yourself on good clinical practices, and eventually pay it forward by mentoring the next generation of researchers.
15 May 2026
Meet Us at the European Hematology Association 2026 Congress, 11–14 June 2026, Stockholm, Sweden
Conference: European Hematology Association 2026 Congress
Date: 11–14 June 2026
Location: Stockholm, Sweden
We are pleased to announce that MDPI will be featured in the upcoming European Hematology Association 2026 Congress (EHA 2026). The EHA 2026 is organized by the European Hematology Association, intended for the global hematology community to share the latest clinical and research updates in the subject of hematology. The conference brings together hematologists, researchers, and healthcare professionals to discuss advancements in blood disorders and treatments.
Topics include, but are not limited to, the following:
- Advancing innovation and scientific discovery across basic, translational, and clinical hematology;
- Enhancing diagnostics, treatment strategies, and evidence-based hematology practice;
- Strengthening collaboration, education, patient communication, and professional development within the hematology community.
The following MDPI journals will be represented:
- Thalassemia Reports;
- Hematology Reports;
- Hemato;
- Transplantology;
- Journal of Clinical Medicine (JCM);
- Journal of Cardiovascular Development and Disease (JCDD);
- Medicina;
- Current Oncology;
- Lymphatics;
- Clinics and Practice;
- Cancers;
- Children;
- Neurology International;
- Surgical Techniques Development;
- Therapeutics.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth H2.04 and answering any questions that you may have. For more information about the conference, please visit the following website: https://ehaweb.org/connect-network/eha2026-congress.








































